Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).


TSXV:VPT - Post by User

Comment by jopatcloon May 14, 2024 11:46am
54 Views
Post# 36038937

RE:RE:Dear Friend;

RE:RE:Dear Friend;good now Adams, George 
Filed 2024-05-14 10:46
 
Tx date 2024-05-10
$VPT
Ventripoint Diagnostics Ltd. (formerly Luca Capital Inc.)
Adams, George
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Debentures
11 - Acquisition or disposition carried out privately
$
+$100 vol
$1,000 each
$150  
Filed 2024-05-13 14:07
 
Tx date 2024-05-10
$VPT
Ventripoint Diagnostics Ltd. (formerly Luca Capital Inc.)
Hodgkinson, Robert
4 - Director of Issuer
Holder: Hodgkinson Equities Corporation (Indirect Ownership)
Debentures
16 - Acquisition or disposition under a prospectus exemption
$
+$250 vol
$1,000 each
$250  
Older filings 
Filed 2024-05-03 08:50
 
Tx date 2024-05-02
$VPT
Ventripoint Diagnostics Ltd. (formerly Luca Capital Inc.)
MacNaught, Hugh
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,420
+20,000 vol
$0.221 each
60,000  
Filed 2024-04-26 11:49
 
Tx date 2024-04-26
$VPT
Ventripoint Diagnostics Ltd. (formerly Luca Capital Inc.)
Hodgkinson, Robert
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$945.00
+4,500 vol
$0.21 each
2,300,001  
Filed 2024-04-25 16:26
 
Tx date 2024-04-25
$VPT
Ventripoint Diagnostics Ltd. (formerly Luca Capital Inc.)
Hodgkinson, Robert
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$9,691
+45,500 vol
$0.213 each
2,295,501  
Filed 2024-04-25 13:47
 
Tx date 2024-04-25
$VPT
Ventripoint Diagnostics Ltd. (formerly Luca Capital Inc.)
Hodgkinson, Robert
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$840.00
+4,000 vol
$0.21 each
2,250,001  
Filed 2024-04-24 16:55
 
Tx date 2024-04-24
$VPT
Ventripoint Diagnostics Ltd. (formerly Luca Capital Inc.)
Hodgkinson, Robert
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,410
+21,000 vol
$0.21 each
2,246,001  
Filed 2024-04-23 14:17
 
Tx date 2024-04-23
$VPT
Ventripoint Diagnostics Ltd. (formerly Luca Capital Inc.)
Hodgkinson, Robert
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$5,425
+25,000 vol
$0.217 each
2,225,001  
Filed 2024-04-22 14:52
 
Tx date 2024-04-22
$VPT
Ventripoint Diagnostics Ltd. (formerly Luca Capital Inc.)
Hodgkinson, Robert
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$5,250
+25,000 vol
$0.21 each
2,200,001  
Filed 2024-04-22 13:08
 
Tx date 2024-04-22
$VPT
Ventripoint Diagnostics Ltd. (formerly Luca Capital Inc.)
Hodgkinson, Robert
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$15,900
+75,000 vol
$0.212 each
2,175,001  
Filed 2024-04-19 13:20
 
Tx date 2024-04-18
$VPT
Ventripoint Diagnostics Ltd. (formerly Luca Capital Inc.)
Hodgkinson, Robert
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$7,774
+36,500 vol
$0.213 each
2,100,001  
Filed 2024-04-19 13:16
 
Tx date 2024-04-17
$VPT
Ventripoint Diagnostics Ltd. (formerly Luca Capital Inc.)
Hodgkinson, Robert
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$13,335
+63,500 vol
$0.21 each
2,063,501  
Filed 2024-04-17 16:23
 
Tx date 2024-04-12
$VPT
Ventripoint Diagnostics Ltd. (formerly Luca Capital Inc.)
MacNaught, Hugh
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,400
+20,000 vol
$0.22 each
40,000  
Filed 2024-03-28 20:40
 
Tx date 2024-03-28
$VPT
Ventripoint Diagnostics Ltd. (formerly Luca Capital Inc.)
MacNaught, Hugh
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,520
+20,000 vol
$0.226 each
20,000

<< Previous
Bullboard Posts
Next >>